US recruitment milestone for trial of Immuron's Travelan

Immuron (ASX:IMC) has updated on the US Department of Defense Uniformed Services University (USU) clinical evaluation of the company's Travelan.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.